Prognostic Impact of Renal Function on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of

Ryosuke Itakura1, Shoichi Kuramitsu2, Jun Kikuchi1

  • 1Department of Cardiovascular Medicine Gifu Heart Center Gifu Japan.

Insights

Patients with end-stage renal disease (ESRD) have a higher risk of target vessel failure (TVF) after deferring coronary intervention based on fractional flow reserve (FFR). However, outcomes were similar for chronic kidney disease (CKD) patients and those without kidney disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • Chronic kidney disease (CKD) may impact the prognostic value of fractional flow reserve (FFR).
  • Limited large-scale data exist on clinical outcomes following FFR-guided deferral of revascularization in CKD patients.

Purpose of the Study:

  • To evaluate the 5-year clinical outcomes after FFR-guided deferral of coronary intervention in patients stratified by renal function.
  • To assess the impact of CKD and end-stage renal disease (ESRD) on target vessel failure (TVF) risk.

Main Methods:

  • Analysis of 1218 patients from the J-CONFIRM registry, categorized into non-CKD (eGFR ≥60), CKD (eGFR 15-59), and ESRD (eGFR <15).
  • Primary endpoint: 5-year cumulative incidence of TVF (cardiac death, target vessel MI, TVR).

Main Results:

  • 5-year TVF incidence was significantly higher in ESRD (26.3%) compared to CKD (11.9%) and non-CKD (9.5%) groups (P<0.001).
  • No significant difference in TVF was observed between CKD and non-CKD groups.
  • ESRD patients exhibited a markedly higher TVF risk across all FFR values compared to non-CKD and CKD patients.

Conclusions:

  • ESRD is associated with increased 5-year TVF risk following FFR-guided deferral of revascularization.
  • CKD patients without ESRD had similar outcomes to non-CKD patients.
  • Renal function significantly modifies the prognostic implications of FFR in guiding coronary intervention decisions.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
105
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
100
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10